MedTrace Logo

Labor Epidural Analgesia and Mother-Infant Bonding After Vaginal Delivery

NCT07582289 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2026-05-12

No results posted yet for this study

Summary

This prospective observational cohort study aims to evaluate the association between postpartum recovery quality and mother-infant bonding in women undergoing vaginal delivery. Postpartum recovery quality will be assessed using the Obstetric Quality of Recovery-10 (ObsQoR-10) questionnaire, and mother-infant bonding will be evaluated using the Postpartum Bonding Questionnaire (PBQ).

Participants will be grouped according to routine clinical labor analgesia preference: women receiving labor epidural analgesia and women not receiving epidural analgesia. Additional assessments will include postpartum pain intensity, anxiety, depressive symptoms, and birth satisfaction.

Baseline psychological assessments will be performed before delivery. The primary postpartum evaluation will be conducted between 6 and 24 hours after delivery. Exploratory follow-up assessments will be performed by telephone during postpartum week 2.

The study aims to better understand the relationship between labor analgesia, postpartum recovery, and early mother-infant bonding outcomes after vaginal delivery.

Conditions

  • Postpartum Recovery
  • Mother-infant Bonding
  • Labor Pain

Interventions

PROCEDURE

Labor Epidural Analgesia

Epidural analgesia administered during labor as part of routine clinical care for pain management during vaginal delivery.

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • Ayşe Ceren Hilal Güven, assistant doctor · Ataturk University Department of Anesthesiology and Reanimation

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-15
Primary Completion
2029-06-16
Completion
2029-06-17

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07582289 on ClinicalTrials.gov